These studies have suggested that the initial pathological changes in the diabetic kidney are associated with low-grade proliferation followed by cellular hypertrophy. In vitro and in vivo studies have shown that the absence of p21 prevents the development of hypertrophy associated with the diabetic kidney [56, 58]. The gene discussed is CDKN1A; the disease is urogenital neoplasm.